Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
This year, Drug and Therapeutics Bulletin (DTB) is celebrating its 60th anniversary and to mark this occasion we are looking back at some of DTB’s early articles.
When DTB was first launched in 1962 there were no drug licensing laws, no formal controls of drug promotion or arrangements for pharmacovigilance, no summaries of product characteristics, and little recognition of the importance of scientific evidence to clinical practice.1 Doctors and drug companies went essentially unquestioned and there was little discussion with patients over details of their illness, treatment options or preferences.
At a time when there were very few independent sources of reliable information on the effects of medicines, DTB’s aim was—and continues to be—‘to provide clinicians with clear, reliable, usable, impartial and independent information to help ensure patients get the best deal’.1
In one of its early …
Contributors Contributors DTB Team.
Provenance and peer review Commissioned; internally peer reviewed.